# OnCo record prrt (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/prrt/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "prrt" ;
  schema:name "Peptide receptor radionuclide therapy (PRRT)"@en ;
  schema:description "A radioactive version of the hormone mimic used for the scan; it homes to neuroendocrine tumour cells and irradiates them from inside."@en ;
  schema:url <https://onco.cc/technologies/prrt/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Peptide_receptor_radionuclide_therapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q55629467> ;
  schema:citation <https://en.wikipedia.org/wiki/Peptide_receptor_radionuclide_therapy> ;
  onco:status "approved" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/targeted-alpha-therapy/>, <https://onco.cc/technologies/sstr-pet/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:drugs <https://onco.cc/drugs/lutathera/>, <https://onco.cc/drugs/itm-11/>, <https://onco.cc/drugs/alphamedix/>, <https://onco.cc/drugs/ryz101/> ;
  onco:companies <https://onco.cc/companies/novartis/>, <https://onco.cc/companies/itm/>, <https://onco.cc/companies/orano-med/>, <https://onco.cc/companies/radiomedix/>, <https://onco.cc/companies/rayzebio/> ;
  onco:trials <https://onco.cc/trials/netter-1/> ;
  onco:dependsOn <https://onco.cc/technologies/radioligand-therapy/>, <https://onco.cc/technologies/sstr-pet/> .